universal hood ii protein imaging system Search Results


99
LI-COR li cor odyssey fc image system
Li Cor Odyssey Fc Image System, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/li cor odyssey fc image system/product/LI-COR
Average 99 stars, based on 1 article reviews
li cor odyssey fc image system - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
VILBER GmbH fusion solo 2m chemiluminescence imaging system
Fusion Solo 2m Chemiluminescence Imaging System, supplied by VILBER GmbH, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fusion solo 2m chemiluminescence imaging system/product/VILBER GmbH
Average 99 stars, based on 1 article reviews
fusion solo 2m chemiluminescence imaging system - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Bio-Rad phosphor imaging system
Phosphor Imaging System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphor imaging system/product/Bio-Rad
Average 90 stars, based on 1 article reviews
phosphor imaging system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

99
LI-COR odyssey imager
Odyssey Imager, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/odyssey imager/product/LI-COR
Average 99 stars, based on 1 article reviews
odyssey imager - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
LI-COR odyssey infrared imaging system
Odyssey Infrared Imaging System, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/odyssey infrared imaging system/product/LI-COR
Average 99 stars, based on 1 article reviews
odyssey infrared imaging system - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Bio-Rad chemidoc xrs imaging system
Chemidoc Xrs Imaging System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chemidoc xrs imaging system/product/Bio-Rad
Average 99 stars, based on 1 article reviews
chemidoc xrs imaging system - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Bio-Rad chemidoc mp imaging system
Chemidoc Mp Imaging System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chemidoc mp imaging system/product/Bio-Rad
Average 99 stars, based on 1 article reviews
chemidoc mp imaging system - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Bio-Rad image lab version 6.1.0
Image Lab Version 6.1.0, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/image lab version 6.1.0/product/Bio-Rad
Average 90 stars, based on 1 article reviews
image lab version 6.1.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc 72971s
72971s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/72971s/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
72971s - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

99
LI-COR odyssey scanning system
Odyssey Scanning System, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/odyssey scanning system/product/LI-COR
Average 99 stars, based on 1 article reviews
odyssey scanning system - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology ve cadherin
Fig. 1. Differentiation of B6 and B6HIP iPSCs into iCMs and iECs. (A) B6 iPSCs were differentiated into iECs and iCMs. (B) During the differentiation, the cells lost their typical pluripotent features of iPSCs and B6 iECs adopted genetic markers of endothelial cells and B6 iCMs of cardiomyocytes (representative gels of two independent experiments). (C and D) B6 iECs <t>expressed</t> <t>Cd31</t> and <t>VE-cadherin</t> (C, representative pictures of five independent experiments) and formed tubular structures in vitro (D, representative pictures of five independent experiments). (E) B6 iCMs expressed alpha-sarcomeric actinin and troponin I (representative pictures of five independent experiments). (F) B6HIP iPSCs were differentiated into iECs and iCMs. (G) During the differentiation, the cells lost their typical pluripotent features of iPSCs and B6HIP iECs adopted genetic markers of endothelial cells and B6HIP iCMs of cardiomyocytes (representative gels of two independent experiments). (H and I) B6HIP iECs expressed Cd31 and VE-cadherin (H, representative pictures of five independent experiments) and formed tubular structures in vitro (I, representative pictures of five independent experiments). (J) B6HIP iCMs expressed alpha-sarcomeric actinin and troponin I (representative pictures of five independent experiments).
Ve Cadherin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ve cadherin/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
ve cadherin - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology antibodies against dsred
Figure 2. The transdifferentiating iLVs switch molecular and structural identities and are restricted to stand-alone iLVs (A–C) The lyve1b+kdrl BLECs in the uninjured control (arrows), but not the transdifferentiating lyve1b+kdrl+ iLVs at 3 dpt after injury (arrowheads), were positive for anti-Prox1 (A) and fluorescence in situ hybridization (FISH)-vegfr3 (B). The statistics show the ratios of vessels positive for anti-Prox1 or FISH-vegfr3 among all the lyve1b+kdrl vessels and all the lyve1b+kdrl+ vessels. (C) (n = 6 larvae; two-way ANOVA by Dunnett’s multiple comparisons test; ***, p < 0.0001). Scale bar, 20 mm. (D and E) Positive control brain BVs in the uninjured larvae (D), the lineage-tracing system indicated that the vessels double positive for GFP and Dendra2 (E, arrow) and single positive for Dendra2 (D and E) expressed the blood-brain barrier marker glut1b, but vessels single positive for GFP (D, arrowhead) did not. Scale bar, 20 mm. (F–H) Single FIB-SEM image planes (right row) indicate cross sections of the vessels shown in the left row. Note that the mural of the <t>DsRed+Dendra2+</t> vessel (G) is similar to the DsRed-Dendra2+ BV (H) but much thicker than the DsRed+Dendra2 iLV (F). Color rings mark the inner and outer surfaces of murals. Arrows indicate blood cells. Scale bars, 20 and 1 mm. (I–L) Live imaging shows BLECs (I), stand-alone iLVs (J, arrows), and track iLVs (K) at 2 and 4 dpt. Note that only the stand-alone iLVs express Dendra2 and recruit the GFP+ pericytes at 4 dpt (J, arrowheads). (L) The statistics show the ratios of transdifferentiation in the stand-alone iLVs and track iLVs at 4 dpt (n = 9 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 50 mm. (M–P) The TUNEL signals in the stand-alone iLVs (M) and track iLVs (N) at 7 dpt. The statistics show the ratios of TUNEL+ cells in stand-alone iLVs and in track iLVs (O) (n = 9 larvae; ***, p < 0.0001), and the ratios of iLVs undergoing transdifferentiation (Dendra2+GFP+) or undergoing apoptosis (GFP+TUNEL+) among all the iLVs at 7 dpt (P) (n = 30 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 50 mm. Data are represented as mean ± SD. See also Figure S2.
Antibodies Against Dsred, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against dsred/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
antibodies against dsred - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Differentiation of B6 and B6HIP iPSCs into iCMs and iECs. (A) B6 iPSCs were differentiated into iECs and iCMs. (B) During the differentiation, the cells lost their typical pluripotent features of iPSCs and B6 iECs adopted genetic markers of endothelial cells and B6 iCMs of cardiomyocytes (representative gels of two independent experiments). (C and D) B6 iECs expressed Cd31 and VE-cadherin (C, representative pictures of five independent experiments) and formed tubular structures in vitro (D, representative pictures of five independent experiments). (E) B6 iCMs expressed alpha-sarcomeric actinin and troponin I (representative pictures of five independent experiments). (F) B6HIP iPSCs were differentiated into iECs and iCMs. (G) During the differentiation, the cells lost their typical pluripotent features of iPSCs and B6HIP iECs adopted genetic markers of endothelial cells and B6HIP iCMs of cardiomyocytes (representative gels of two independent experiments). (H and I) B6HIP iECs expressed Cd31 and VE-cadherin (H, representative pictures of five independent experiments) and formed tubular structures in vitro (I, representative pictures of five independent experiments). (J) B6HIP iCMs expressed alpha-sarcomeric actinin and troponin I (representative pictures of five independent experiments).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice.

doi: 10.1073/pnas.2022091118

Figure Lengend Snippet: Fig. 1. Differentiation of B6 and B6HIP iPSCs into iCMs and iECs. (A) B6 iPSCs were differentiated into iECs and iCMs. (B) During the differentiation, the cells lost their typical pluripotent features of iPSCs and B6 iECs adopted genetic markers of endothelial cells and B6 iCMs of cardiomyocytes (representative gels of two independent experiments). (C and D) B6 iECs expressed Cd31 and VE-cadherin (C, representative pictures of five independent experiments) and formed tubular structures in vitro (D, representative pictures of five independent experiments). (E) B6 iCMs expressed alpha-sarcomeric actinin and troponin I (representative pictures of five independent experiments). (F) B6HIP iPSCs were differentiated into iECs and iCMs. (G) During the differentiation, the cells lost their typical pluripotent features of iPSCs and B6HIP iECs adopted genetic markers of endothelial cells and B6HIP iCMs of cardiomyocytes (representative gels of two independent experiments). (H and I) B6HIP iECs expressed Cd31 and VE-cadherin (H, representative pictures of five independent experiments) and formed tubular structures in vitro (I, representative pictures of five independent experiments). (J) B6HIP iCMs expressed alpha-sarcomeric actinin and troponin I (representative pictures of five independent experiments).

Article Snippet: The iEC phenotype was confirmed by immunofluorescence (IF) for expression of Cd31 (ab28364, Abcam), and VE-cadherin (sc-6458, Santa Cruz Biotechnology) with secondary antibodies conjugated with AF488 or AF555 (Invitrogen).

Techniques: In Vitro

Fig. 2. Allogeneic HIP iECs facilitate ischemic limb preservation. (A) In BALB/c mice, the superficial femoral artery was ligated and partially resected to induce left lower limb ischemia. (B) Mice were left untreated or received fan-shaped injections of allo or alloHIP iECs into the surrounding tissue. (C) The study protocol included assessment of iEC survival and laser Doppler perfusion imaging and histology after 28 d. (D and E) The survival of FLuc+ iEC grafts was longitudinally followed by BLI. All allo iEC grafts were rejected over 15 d (D, 5 animals), while all alloHIP iEC grafts survived and some grafts even showed proliferation (E, 15 animals). BLI signals of individual animals are plotted, representative pictures are shown. (F) Left lower extremity perfusion was serially assessed by laser Doppler imaging and showed an improvement over time only after transplantation of alloHIP iECs (mean ± SD, 15 animals with no cell injection, 5 animals in the allo group, and 15 animals in the alloHIP group; ANOVA with Bonferroni post hoc test). (G) The sequelae of CLI after 28 d were graded according to a standardized scoring system and showed improved limb preservation with alloHIP iEC treatment (parts of whole graphs, 15 animals with no cell injection, 5 animals in the WT group, 15 animals in the HIP group; Kruskal–Wallis test). (H) Immunofluorescence staining showed no engrafted FLuc+ allo iECs in allogeneic BALB/c recipients, but engraftment of FLuc+ alloHIP iECs located along the endothelial layer of larger and smaller intramuscular vessels. Costaining showed that transplanted cells retained their VE-cadherin expression (representative pictures of five independent experiments).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice.

doi: 10.1073/pnas.2022091118

Figure Lengend Snippet: Fig. 2. Allogeneic HIP iECs facilitate ischemic limb preservation. (A) In BALB/c mice, the superficial femoral artery was ligated and partially resected to induce left lower limb ischemia. (B) Mice were left untreated or received fan-shaped injections of allo or alloHIP iECs into the surrounding tissue. (C) The study protocol included assessment of iEC survival and laser Doppler perfusion imaging and histology after 28 d. (D and E) The survival of FLuc+ iEC grafts was longitudinally followed by BLI. All allo iEC grafts were rejected over 15 d (D, 5 animals), while all alloHIP iEC grafts survived and some grafts even showed proliferation (E, 15 animals). BLI signals of individual animals are plotted, representative pictures are shown. (F) Left lower extremity perfusion was serially assessed by laser Doppler imaging and showed an improvement over time only after transplantation of alloHIP iECs (mean ± SD, 15 animals with no cell injection, 5 animals in the allo group, and 15 animals in the alloHIP group; ANOVA with Bonferroni post hoc test). (G) The sequelae of CLI after 28 d were graded according to a standardized scoring system and showed improved limb preservation with alloHIP iEC treatment (parts of whole graphs, 15 animals with no cell injection, 5 animals in the WT group, 15 animals in the HIP group; Kruskal–Wallis test). (H) Immunofluorescence staining showed no engrafted FLuc+ allo iECs in allogeneic BALB/c recipients, but engraftment of FLuc+ alloHIP iECs located along the endothelial layer of larger and smaller intramuscular vessels. Costaining showed that transplanted cells retained their VE-cadherin expression (representative pictures of five independent experiments).

Article Snippet: The iEC phenotype was confirmed by immunofluorescence (IF) for expression of Cd31 (ab28364, Abcam), and VE-cadherin (sc-6458, Santa Cruz Biotechnology) with secondary antibodies conjugated with AF488 or AF555 (Invitrogen).

Techniques: Preserving, Imaging, Transplantation Assay, Injection, Immunofluorescence, Staining, Expressing

Figure 2. The transdifferentiating iLVs switch molecular and structural identities and are restricted to stand-alone iLVs (A–C) The lyve1b+kdrl BLECs in the uninjured control (arrows), but not the transdifferentiating lyve1b+kdrl+ iLVs at 3 dpt after injury (arrowheads), were positive for anti-Prox1 (A) and fluorescence in situ hybridization (FISH)-vegfr3 (B). The statistics show the ratios of vessels positive for anti-Prox1 or FISH-vegfr3 among all the lyve1b+kdrl vessels and all the lyve1b+kdrl+ vessels. (C) (n = 6 larvae; two-way ANOVA by Dunnett’s multiple comparisons test; ***, p < 0.0001). Scale bar, 20 mm. (D and E) Positive control brain BVs in the uninjured larvae (D), the lineage-tracing system indicated that the vessels double positive for GFP and Dendra2 (E, arrow) and single positive for Dendra2 (D and E) expressed the blood-brain barrier marker glut1b, but vessels single positive for GFP (D, arrowhead) did not. Scale bar, 20 mm. (F–H) Single FIB-SEM image planes (right row) indicate cross sections of the vessels shown in the left row. Note that the mural of the DsRed+Dendra2+ vessel (G) is similar to the DsRed-Dendra2+ BV (H) but much thicker than the DsRed+Dendra2 iLV (F). Color rings mark the inner and outer surfaces of murals. Arrows indicate blood cells. Scale bars, 20 and 1 mm. (I–L) Live imaging shows BLECs (I), stand-alone iLVs (J, arrows), and track iLVs (K) at 2 and 4 dpt. Note that only the stand-alone iLVs express Dendra2 and recruit the GFP+ pericytes at 4 dpt (J, arrowheads). (L) The statistics show the ratios of transdifferentiation in the stand-alone iLVs and track iLVs at 4 dpt (n = 9 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 50 mm. (M–P) The TUNEL signals in the stand-alone iLVs (M) and track iLVs (N) at 7 dpt. The statistics show the ratios of TUNEL+ cells in stand-alone iLVs and in track iLVs (O) (n = 9 larvae; ***, p < 0.0001), and the ratios of iLVs undergoing transdifferentiation (Dendra2+GFP+) or undergoing apoptosis (GFP+TUNEL+) among all the iLVs at 7 dpt (P) (n = 30 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 50 mm. Data are represented as mean ± SD. See also Figure S2.

Journal: Developmental cell

Article Title: Acute brain vascular regeneration occurs via lymphatic transdifferentiation.

doi: 10.1016/j.devcel.2021.09.005

Figure Lengend Snippet: Figure 2. The transdifferentiating iLVs switch molecular and structural identities and are restricted to stand-alone iLVs (A–C) The lyve1b+kdrl BLECs in the uninjured control (arrows), but not the transdifferentiating lyve1b+kdrl+ iLVs at 3 dpt after injury (arrowheads), were positive for anti-Prox1 (A) and fluorescence in situ hybridization (FISH)-vegfr3 (B). The statistics show the ratios of vessels positive for anti-Prox1 or FISH-vegfr3 among all the lyve1b+kdrl vessels and all the lyve1b+kdrl+ vessels. (C) (n = 6 larvae; two-way ANOVA by Dunnett’s multiple comparisons test; ***, p < 0.0001). Scale bar, 20 mm. (D and E) Positive control brain BVs in the uninjured larvae (D), the lineage-tracing system indicated that the vessels double positive for GFP and Dendra2 (E, arrow) and single positive for Dendra2 (D and E) expressed the blood-brain barrier marker glut1b, but vessels single positive for GFP (D, arrowhead) did not. Scale bar, 20 mm. (F–H) Single FIB-SEM image planes (right row) indicate cross sections of the vessels shown in the left row. Note that the mural of the DsRed+Dendra2+ vessel (G) is similar to the DsRed-Dendra2+ BV (H) but much thicker than the DsRed+Dendra2 iLV (F). Color rings mark the inner and outer surfaces of murals. Arrows indicate blood cells. Scale bars, 20 and 1 mm. (I–L) Live imaging shows BLECs (I), stand-alone iLVs (J, arrows), and track iLVs (K) at 2 and 4 dpt. Note that only the stand-alone iLVs express Dendra2 and recruit the GFP+ pericytes at 4 dpt (J, arrowheads). (L) The statistics show the ratios of transdifferentiation in the stand-alone iLVs and track iLVs at 4 dpt (n = 9 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 50 mm. (M–P) The TUNEL signals in the stand-alone iLVs (M) and track iLVs (N) at 7 dpt. The statistics show the ratios of TUNEL+ cells in stand-alone iLVs and in track iLVs (O) (n = 9 larvae; ***, p < 0.0001), and the ratios of iLVs undergoing transdifferentiation (Dendra2+GFP+) or undergoing apoptosis (GFP+TUNEL+) among all the iLVs at 7 dpt (P) (n = 30 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 50 mm. Data are represented as mean ± SD. See also Figure S2.

Article Snippet: Antibody staining, combination of FISH and antibody staining Whole-mount antibody staining and combination of FISH and antibody staining were performed as previously described (Chen et al., 2019; Liu et al., 2016; He et al., 2019, 2020) using antibodies against DsRed (1:200, Santa-Cruz), GFP or Venus (1:500, Abcam and Santa Cruz), Dendra2 (1:500, Antibody-online), Prox1 (1:1000, Abcam), and phospho-EphB4a (1:250, Signalway Antibody).

Techniques: Control, In Situ Hybridization, Positive Control, Marker, Imaging, Two Tailed Test, TUNEL Assay

Figure 4. Defective EphB4a leads to derepression of Notch in the track iLVs (A–L) Triple labeling of anti-Dendra2, anti-GFP, and FISH-dll4 (A–C)/notch1a (E–G)/hey1 (I–K). In the siblings, dll4/notch1a/hey1 were activated in the Dendra2+GFP+ stand-alone iLVs (A, E, and I) and Dendra2+GFP nascent BVs (B, F, and J), but not in the Dendra2GFP+ track iLVs (B, F, and J). By contrast, in the ephB4a mutant, the Dendra2GFP+ track iLVs at 3 dpt also exhibited dll4, notch1a, and hey1 expressions (C, G, and K). The statistics show the dll4/notch1a/ hey1 expression in the vessels of sibling and ephB4a mutant (D, H, and L) (n = 6 larvae; two-tailed unpaired t test; ***, p < 0.0001). (M–P) The Notch functional reporter tp1:Venus was activated in the Dendra2+DsRed+ stand-alone iLVs (M) and Dendra2+DsRed nascent BVs (N), but not in the Dendra2DsRed+ track iLVs (N). By contrast, in the ephB4a mutant, the Dendra2DsRed+ track iLVs at 3 dpt also exhibited Venus expression (O). The statistics show the tp1:Venus expression in the vessels of siblings and ephB4a mutants (P) (n = 6 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 20 mm. Data are represented as mean ± SD. See also Figures S6 and S7.

Journal: Developmental cell

Article Title: Acute brain vascular regeneration occurs via lymphatic transdifferentiation.

doi: 10.1016/j.devcel.2021.09.005

Figure Lengend Snippet: Figure 4. Defective EphB4a leads to derepression of Notch in the track iLVs (A–L) Triple labeling of anti-Dendra2, anti-GFP, and FISH-dll4 (A–C)/notch1a (E–G)/hey1 (I–K). In the siblings, dll4/notch1a/hey1 were activated in the Dendra2+GFP+ stand-alone iLVs (A, E, and I) and Dendra2+GFP nascent BVs (B, F, and J), but not in the Dendra2GFP+ track iLVs (B, F, and J). By contrast, in the ephB4a mutant, the Dendra2GFP+ track iLVs at 3 dpt also exhibited dll4, notch1a, and hey1 expressions (C, G, and K). The statistics show the dll4/notch1a/ hey1 expression in the vessels of sibling and ephB4a mutant (D, H, and L) (n = 6 larvae; two-tailed unpaired t test; ***, p < 0.0001). (M–P) The Notch functional reporter tp1:Venus was activated in the Dendra2+DsRed+ stand-alone iLVs (M) and Dendra2+DsRed nascent BVs (N), but not in the Dendra2DsRed+ track iLVs (N). By contrast, in the ephB4a mutant, the Dendra2DsRed+ track iLVs at 3 dpt also exhibited Venus expression (O). The statistics show the tp1:Venus expression in the vessels of siblings and ephB4a mutants (P) (n = 6 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 20 mm. Data are represented as mean ± SD. See also Figures S6 and S7.

Article Snippet: Antibody staining, combination of FISH and antibody staining Whole-mount antibody staining and combination of FISH and antibody staining were performed as previously described (Chen et al., 2019; Liu et al., 2016; He et al., 2019, 2020) using antibodies against DsRed (1:200, Santa-Cruz), GFP or Venus (1:500, Abcam and Santa Cruz), Dendra2 (1:500, Antibody-online), Prox1 (1:1000, Abcam), and phospho-EphB4a (1:250, Signalway Antibody).

Techniques: Labeling, Mutagenesis, Expressing, Two Tailed Test, Functional Assay

Figure 5. EphB4a represses track iLV transdifferentiation through suppression of Notch (A–C) The derepressed transdifferentiation of track iLV (Dendra2+DsRed+) in the ephB4a mutant (A, arrow) was rescued by treatment with DAPT, which returned to Dendra2DsRed+ (B, arrowheads). The statistics show the ratios of transdifferentiation among track iLVs in the ephB4a mutant with or without DAPT treatment (C) (n = 10 larvae; two-tailed unpaired t test; ***, p < 0.0001). (D–G) The derepressed transdifferentiation of track iLV (Dendra2+GFP+) in the ephB4a mutant without heat shock (D, arrow) or without dnMAML-Flag (E, arrow) was rescued by the heat-shock-induced, LEC-specific overexpression of dnMAML-Flag, which exhibited Dendra2GFP+ at 4 dpt (F, arrowhead). The statistics show the ratios of transdifferentiation among track iLVs in the ephB4a mutant groups (G) (n = 10 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 20 mm. Data are represented as mean ± SD. HS, heat shock. See also Figures S6 and S7.

Journal: Developmental cell

Article Title: Acute brain vascular regeneration occurs via lymphatic transdifferentiation.

doi: 10.1016/j.devcel.2021.09.005

Figure Lengend Snippet: Figure 5. EphB4a represses track iLV transdifferentiation through suppression of Notch (A–C) The derepressed transdifferentiation of track iLV (Dendra2+DsRed+) in the ephB4a mutant (A, arrow) was rescued by treatment with DAPT, which returned to Dendra2DsRed+ (B, arrowheads). The statistics show the ratios of transdifferentiation among track iLVs in the ephB4a mutant with or without DAPT treatment (C) (n = 10 larvae; two-tailed unpaired t test; ***, p < 0.0001). (D–G) The derepressed transdifferentiation of track iLV (Dendra2+GFP+) in the ephB4a mutant without heat shock (D, arrow) or without dnMAML-Flag (E, arrow) was rescued by the heat-shock-induced, LEC-specific overexpression of dnMAML-Flag, which exhibited Dendra2GFP+ at 4 dpt (F, arrowhead). The statistics show the ratios of transdifferentiation among track iLVs in the ephB4a mutant groups (G) (n = 10 larvae; two-tailed unpaired t test; ***, p < 0.0001). Scale bar, 20 mm. Data are represented as mean ± SD. HS, heat shock. See also Figures S6 and S7.

Article Snippet: Antibody staining, combination of FISH and antibody staining Whole-mount antibody staining and combination of FISH and antibody staining were performed as previously described (Chen et al., 2019; Liu et al., 2016; He et al., 2019, 2020) using antibodies against DsRed (1:200, Santa-Cruz), GFP or Venus (1:500, Abcam and Santa Cruz), Dendra2 (1:500, Antibody-online), Prox1 (1:1000, Abcam), and phospho-EphB4a (1:250, Signalway Antibody).

Techniques: Mutagenesis, Two Tailed Test, Over Expression